Physician profile
James A Murray
NPI 1043398399
$4,805.90
in general payments reported to CMS, 2019-2025
28 companies · $1,929 in 2025
The $1,929 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.91 · 2020: $171 · 2021: $278 · 2022: $424 · 2023: $892 · 2024: $1,087 · 2025: $1,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,568 · Education: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,567.88 |
| Education | $339.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,925.83 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $427.18 | 2020-2025 | Tezspire, Airsupra, Fasenra |
| Grifols USA, LLC | $220.87 | 2021-2025 | Prolastin-C Liquid |
| Amgen INC. | $209.90 | 2024-2025 | Tezspire |
| Electromed, INC. | $198.57 | 2024-2025 | Smartvest |
| Astellas Pharma US INC | $189.62 | 2025 | Cresemba |
| Insmed, INC. | $184.59 | 2025 | Arikayce, Brinsupri |
| Jazz Pharmaceuticals INC. | $180.54 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.49 | 2019-2025 | Ofev |
| Genzyme Corporation | $117.21 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $113.23 | 2024-2025 | Opsumit, Uptravi |
| Verona Pharma, INC. | $98.47 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $85.51 | 2021-2025 | Dupixent |
| Baxter Healthcare | $77.71 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Fisher & Paykel Healthcare INC | $73.78 | 2023-2024 | Fisher & Paykel Healthcare |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $70.13 | 2022-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Axsome Therapeutics, INC. | $68.60 | 2023-2024 | Sunosi |
| Merck Sharp & Dohme LLC | $67.93 | 2019-2023 | Belsomra |
| Takeda Pharmaceuticals U.S.A., INC. | $50.53 | 2023-2024 | Glassia |
| Inogen, INC. | $50.06 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pfizer INC. | $48.98 | 2023 | |
| Lilly USA, LLC | $40.19 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $38.56 | 2023-2024 | Inspire |
| Harmony Biosciences LLC | $35.77 | 2021-2024 | |
| Alk-Abello, INC | $35.43 | 2024 | Grastek, Odactra, Ragwitek |
| Boston Scientific Corporation | $25.17 | 2024 | |
| Janssen Pharmaceuticals, INC | $19.08 | 2022 | |
| Philips North America LLC | $16.97 | 2024 | (Ak6) Vest Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.